ST. LOUIS — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio“) for its TUNR Flexible Gene Editing technology in Japan. Cosmo Bio is one of Japan’s largest and most established reagents and services suppliers in the life science industry, […]
When Ricky Ramon was 7, he went for a routine checkup. The pediatrician, who lingered over his heartbeat, sent him for a chest X-ray, which revealed a benign tumor in the top-left chamber of his heart. For Ramon, it was the beginning of a long series of medical appointments, procedures and surgeries that would span […]
SMRT Sequencing Offers Significant Improvements for Reference Genomes at Much Lower Cost MENLO PARK, Calif. — A new publication in Nature reveals the significant quality improvement afforded by Single Molecule, Real-Time (SMRT®) Sequencing for the maize genome, with implications for other complex crop and livestock genomes. This new PacBio® genome assembly, produced by scientists at Cold Spring […]
Oncomine Dx Target Test returns results in days, helping physicians rapidly develop treatment plans for the most common form of lung cancer CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific for the first next-generation sequencing (NGS)-based test that simultaneously screens tumor samples for biomarkers associated with […]
Budapest, Hungary – University of Debrecen (UD), Hungary and BGI Group signed a Memorandum of Understanding, Tuesday 20th June, regarding cooperation on the establishment of a local NGS sequencing hub for local population cohort studies and diagnostic testing, and wider collaboration in the research and development of genetic and genomic sciences. The MOU was signed […]
LONDON, ON – 3M announced today that Health Canada has approved and published the next-generation 3M Molecular Detection System assay for Listeria detection. Based on isothermal DNA amplification and bioluminescence detection – the same combination of advanced technologies used in all 3M Molecular Detection Assays – these assays use new chemistry to deliver accurate results with shorter […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), today announced the launch of ddPCR™ Genome Edit Detection Assays, the first tests to characterize edits generated by CRISPR-Cas9 or other genome editing tools using Bio-Rad’s Droplet Digital PCR (ddPCR) technology. Users can specify their sequences and order assays through Bio-Rad’s Digital Assay Site. Successful genome editing is […]
Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing 4P Health Research […]
SANTA BARBARA, Calif. — SerImmune Inc. today announced an $8 million round of financing, led by Illumina Ventures, with participation from Merck, known as MSD outside the United States and Canada, through a subsidiary, and additional undisclosed investors. With the proceeds, SerImmune will expand its immune mapping technology platform and antibody repertoire database while building strategic […]
A New Orleans startup exploring the diagnostic aspects of genetic research has received more than $1 million from investors and plans to expand its business. Pine Biotech, based at the New Orleans BioInnovation Center on Canal Street, has developed a software program to help scientists analyze and map large sets of molecular data — also […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
